ArticlePloS one2025

Protocol: Filgotinib in addition to methotrexate versus filgotinib monotherapy in patients with rheumatoid arthritis with an inadequate response to methotrexate: A multicenter, prospective, open-label, randomized controlled trial (FAITHFUL Study).

Mitsuhiro Akiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.